Physician profile
George Adam
NPI 1316902562
$748.51
in general payments reported to CMS, 2019-2025
10 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.51 · 2020: $36.38 · 2021: $111 · 2022: $170 · 2023: $213 · 2024: $40.46 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.54 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $394.68 | 2021-2023 | |
| Amgen INC. | $133.17 | 2020-2025 | Tavneos |
| Calliditas Therapeutics US INC. | $47.69 | 2025 | Tarpeyo |
| Harmony Biosciences LLC | $42.82 | 2023-2024 | Wakix |
| Alexion Pharmaceuticals, INC. | $42.61 | 2025 | Ultomiris |
| Avadel Cns Pharmaceuticals, LLC | $21.13 | 2024 | Lumryz |
| Kyowa Kirin, INC. | $19.85 | 2025 | |
| Novo Nordisk INC | $19.05 | 2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $14.00 | 2025 | Shingrix |
| Resmed Corp | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Adam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.